Candidature YC de Gamgee

Summer 2026Active

San Francisco

Gamgee a été sélectionné par Y Combinator dans le cadre du batch Summer 2026 en tant qu'entreprise Healthcare. Ci-dessous : ce que fait l'entreprise, qui l'a fondée, et sa candidature à YC, reconstruite question par question dans le vrai formulaire YC.

Batch YC: Summer 2026
Secteur d'activité: HealthcareDrug Discovery and Delivery
Lieu: San Francisco
Taille de l'équipe: 2
Statut: Active
Lancé: 2026

Fondateurs

Paul ConynghamFounder/CEO

Ce que fait Gamgee

Gamgee began with Rosie, founder Paul Conyngham’s dog. After surgery, chemotherapy and immunotherapy failed, Rosie was given months to live. Paul used AI and genomic analysis to identify targets in her tumour, then worked with scientists at UNSW to produce what is believed to be the first fully computationally designed mRNA cancer vaccine delivered to a dog. Following treatment, several tumours shrank significantly and her quality of life improved Gamgee is building an end to end platform for personalised mRNA cancer vaccines for dogs. We sequence a dog’s tumour and healthy DNA, identify mutations unique to its cancer, and design a vaccine that teaches the immune system what to attack. We manage the entire process- from vet intake and tissue collection through genomic analysis, vaccine production, treatment and response monitoring We are now turning that one off effort into a repeatable clinical system. Gamgee is running clinical trials in Australia, working with vets, oncologists and specialised laboratories, and accepting cases globally. Our goal is to make personalised cancer treatment accessible to every dog that needs it- and use each case to improve the treatment for the next

Candidature YC de Gamgee, reconstruite

Candidature Y Combinator

Gamgee, promotion Summer 2026. Les vraies questions de candidature, répondues à partir de données publiques.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Gamgee

Describe what your company does in 50 characters or less.

Personalised mRNA cancer vaccines for dogs.

What is your company going to make? Please describe your product and what it does or will do.

We're building an end-to-end platform for personalised mRNA cancer vaccines for dogs. We start by sequencing a dog's tumour and normal tissue, then use AI to identify and rank tumour-specific mutations. Our platform designs a custom mRNA vaccine targeting these mutations, coordinates production, and works with vets to oversee treatment and monitor outcomes.

Where do you live now, and where would the company be based after YC?

San Francisco, CA, USA; Remote. The company would remain based there after YC.

Explain your decision regarding location.

San Francisco connects us to both biotech resources and the YC ecosystem. We operate remotely to collaborate with labs, vets, and trial sites in Australia and globally.

21 réponses supplémentaires dans la candidature complète

se trouvent dans la version complète. Créez un compte gratuit pour l'ouvrir dans YC Insights, à côté de tous les autres batches YC.

Voir la candidature complète

Questions fréquemment posées

Est-ce la vraie candidature YC de Gamgee ?

Non. Y Combinator garde les candidatures soumises privées. Ceci est une reconstruction : les vraies questions du formulaire YC, répondues à partir des données publiques de Gamgee (notes de lancement, parcours des fondateurs, description du produit). Cela montre comment une entreprise comme Gamgee se présenterait à YC, pas le texte qu'ils ont soumis.

À quel batch YC Gamgee appartenait-il ?

Gamgee faisait partie du batch Summer 2026 de Y Combinator.

Qui a fondé Gamgee ?

Gamgee a été fondé par Paul Conyngham.

Que fait Gamgee ?

Curing cancer. Starting with dogs.

Comment lire la candidature complète reconstruite ?

Créez un compte Round Funded gratuit. La version complète de la candidature de Gamgee en 26 réponses, et de chaque autre promotion YC, se trouve dans YC Insights.